研報掘金丨方正證券:維持邁瑞醫療“強烈推薦”評級,三大業務板塊穩健增長
方正證券研報指出,邁瑞醫療是國內醫療器械龍頭,三大業務板塊穩健增長,在“三瑞”數智化解決方案賦能下,持續拓展國內外市場,尤其是加速出海產品矩陣的高端升級和高端客户突破,有望持續高增長,加之微創外科、動物醫療、心血管等種子業務快速發展,整體營收規模行業領先,並在高端化+AI數智化+國際化的多輪驅動下,公司有望持續提升國內外市場份額,實現穩健業績增長和較高的盈利水平,具備可觀的業績成長確定性和可及空間。維持“強烈推薦”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.